- 商品介绍
- 规格参数
- 包装参数
产品介绍
Product Description
Biochem/physiol Actions
NVP-RXI570 is an orally active, potent, and selective allosteric dual inhibitor of BRM ((SMARCA2) and BRG1 (SMARCA4) that that downregulates BRM-dependent gene expression. NVP-RXI570 exhibits antiproliferative activity in a BRG1 mutant-lung-tumor xenograft model.
Orally active, potent, and selective allosteric dual inhibitor of BRM ((SMARCA2) and BRG1 (SMARCA4)
技术参数
Specifications
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | O=C(NC1=CC(F)=NC=C1CO)NC2=CC(C(F)F)=NS2 |
| InChI | 1S/C11H9F3N4O2S/c12-8-1-6(5(4-19)3-15-8)16-11(20)17-9-2-7(10(13)14)18-21-9/h1-3,10,19H,4H2,(H2,15,16,17,20) |
| InChI key | CKYCAIAVJIFWPE-UHFFFAOYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
猜你喜欢
-
¥ 2707.32
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 10277.12
-
¥ 1568.60
-
¥ 2842.54
-
¥ 3319.60
-
¥ 1783.21
-
¥ 1586.69
-
¥ 954.17
-
¥ 5990.26
-
¥ 64659.66
-
¥ 65710.50
-
¥ 22322.85
-
¥ 99441.38
-
询价
-
¥ 57595.03
微信小程序
7X24小时在线咨询